Daniel Patrick McGuire
CIK: 0002138590
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
VNDA
Vanda Pharmaceuticals Inc.
Officer
Discretionary Trading P&L
Holdings
About McGuire Daniel Patrick
McGuire Daniel Patrick (SEC CIK 0002138590) files insider reports with the SEC as SVP, GC and Secretary of Vanda Pharmaceuticals Inc. (VNDA).
Signal8 holds 2 ownership filings by McGuire Daniel Patrick (1 Form 3, 1 Form 4), filed on Jun 8, 2026. Those filings report 1 transaction, the latest on Jun 4, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on McGuire Daniel Patrick's filings is in WASHINGTON, DC.
Recent filings by McGuire Daniel Patrick
- Jun 4, 2026: Grant or award of VNDA shares (Form 4, code A).
Other insiders filing for Vanda Pharmaceuticals Inc. (VNDA)
- Chrousos Phaedra, Director
- Duncan Charles Cliff, Director
- DUGAN RICHARD W, Director
- Ward Anne Sempowski, Director
- Honore Tage, Director
- Mitchell Stephen Ray, Director